Sandra Hagenbrock, who was national account director at Sun in the US and employed there from February 2016 to July 2019, alleged the company asked her to carry out off-label promotions of drugs, which she said was prohibited by federal laws.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33I1K6w
via IFTTT
0 comments:
Post a Comment